Philip Vickers, Faze Medicines CEO
Updated: Two years after launch, Third Rock-backed neuro startup Faze Medicines is closing its doors — report
In 2020, the biotech market was propelled upward by Covid-19, as money flowed quickly into the industry. In December of that year, Faze Medicines launched …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
